Qlarity Imaging, based in Chicago IL, is a leading provider of AI-driven technology for breast imaging. Their mission is to ensure accurate and timely diagnosis, vital for early detection of breast cancer and ultimately saving lives. By leveraging AI technology, they empower radiologists, health systems, and patients, offering valuable insights and improving patient care.

Qlarity's flagship product, QuantX™, is designed to enhance reader accuracy and improve radiologist performance during breast MRI exams. It features a comprehensive multi-modality image viewer and a breast MRI biopsy module. QuantX™ assists in the assessment and characterization of breast abnormalities from MRI data in various clinical scenarios, including high-risk screening, diagnostic imaging workup, and evaluating the extent of known diseases.

In collaboration with strategic partnerships, such as Blackford Platform™, Qlarity Imaging continues to innovate, integrating diagnostic AI and next-generation reporting technologies. Their solutions optimize workflows, improve clinical accuracy, and deliver better outcomes for the hundreds of thousands of women diagnosed with breast cancer each year. Qlarity Imaging is dedicated to advancing breast imaging and supporting healthcare professionals in their mission to provide the highest level of care